A Phase I Clinical Trial to Evaluate the Pharmacokinetic Characteristics of Ammoxetine Hydrochloride Enteric-Coated Tablets in Participants With Moderate Renal Impairment and Normal Renal Function

Clinical trial NCT07694869 · RECRUITING

Trial details

NCT number: NCT07694869
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants Participants With Moderate Renal Impairment

Start date: 2026-05-10
Primary completion: 2026-10-10
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.